CardioMEMS HF System Coverage With Evidence Development Study
NCT: NCT06779552 ·
Status: RECRUITING ·
Phase: N/A
· Sponsor: Abbott Medical Devices
· Started: 2025-02-07
· Est. Completion: 2032-03
Official Summary
The purpose of the CardioMEMS CED Study is to determine if pulmonary artery (PA) pressure-guided heart failure management using the CardioMEMS™ HF System improves long-term health outcomes in heart failure (HF) patients in the real-world setting.
Study Design
- Study Type: OBSERVATIONAL
- Enrollment: 1,000 participants
Interventions
- DEVICE: CardioMEMS HF System — PA Pressure Sensor
Primary Outcomes
- HF Hospitalization Rate. (2 years)
Secondary Outcomes
- Two-Year Survival (2 years)
Trial Locations
- Abbott, Pleasanton, California, United States
More Heart Failure Trials
AI-generated analysis for educational purposes only. This is not medical advice. Discuss clinical trial participation with your doctor. Data sourced from ClinicalTrials.gov.